)
Century Therapeutics (IPSC) investor relations material
Century Therapeutics Chardan’s 9th Annual Genetic Medicines Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic focus and pipeline evolution
Accelerating core programs, including CNTY-101 (NK cell-based, CD19 CAR) and CNTY-308 (iPSC-derived alpha-beta T cells), with clinical and preclinical trials in autoimmune and B-cell-mediated diseases.
CNTY-308 is in IND-enabling studies, targeting clinical entry mid-next year, representing a first in generating autologous-like T cells from iPSC.
A new non-immune cell program is advancing rapidly, positioned in a non-competitive space.
Restructuring has focused resources on key assets and extended cash runway through 2027.
Technological advancements and alloevasion platform
Industry-leading alloevasion technology has evolved from 1.0 (in CNTY-101) to 5.0 (in CNTY-308 and preclinical programs), providing robust immune evasion.
Alloevasion 5.0 includes CD300A “taser” for universal NK cell defense and an IgG-degrading protease for humoral protection.
These edits enable off-the-shelf cell therapies with enhanced persistence and reduced need for lymphodepletion.
Proprietary differentiation process yields tunable mixtures of CD4 and CD8 T cells, matching autologous CAR T efficacy.
Clinical and preclinical data highlights
iPSC-derived T cells show comparable efficacy, proliferation, and persistence to autologous CAR T cells in preclinical models, including durable tumor control and re-challenge response.
NK cell-based CNTY-101 is in two clinical trials (Calypso and Caramel) for autoimmune diseases, with flexible dosing and strong safety profile.
Deep, sustained B cell depletion and tissue penetration observed in B cell malignancy and autoimmune trials, with alloevasion enabling persistence without lymphodepletion.
Data readouts from Calypso are expected this year, with aggregation of data from both trials as possible.
Next Century Therapeutics earnings date
Next Century Therapeutics earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)